Your browser doesn't support javascript.
Why Do HIV Pre-Exposure Prophylaxis Users Discontinue Pre-Exposure Prophylaxis Care? A Mixed Methods Survey in a Pre-Exposure Prophylaxis Clinic in Belgium.
Vanbaelen, Thibaut; Rotsaert, Anke; Jacobs, Bart K M; Florence, Eric; Kenyon, Chris; Vuylsteke, Bea; Laga, Marie; Thijs, Reyniers.
  • Vanbaelen T; Department of Clinical Sciences and Institute of Tropical Medicine, Antwerp, Belgium.
  • Rotsaert A; Department of Public Health, Institute of Tropical Medicine, Antwerp, Belgium.
  • Jacobs BKM; Department of Public Health, Institute of Tropical Medicine, Antwerp, Belgium.
  • Florence E; Department of Clinical Sciences and Institute of Tropical Medicine, Antwerp, Belgium.
  • Kenyon C; Department of Clinical Sciences and Institute of Tropical Medicine, Antwerp, Belgium.
  • Vuylsteke B; Department of Clinical Sciences and Institute of Tropical Medicine, Antwerp, Belgium.
  • Laga M; Division of Infectious Diseases and HIV Medicine, University of Cape Town, Cape Town, South Africa.
  • Thijs R; Department of Public Health, Institute of Tropical Medicine, Antwerp, Belgium.
AIDS Patient Care STDS ; 36(4): 159-167, 2022 04.
Article in English | MEDLINE | ID: covidwho-1795404
ABSTRACT
It remains unclear why patients discontinue HIV pre-exposure prophylaxis (PrEP) care and to what extent they remain at risk for HIV when they do. We reviewed routinely collected medical records and patient questionnaires and performed an e-mail/telephone survey to assess reasons for discontinuing PrEP care, ongoing risks for HIV infection, and associated factors. Patients with more than two registered PrEP visits from a PrEP clinic in Antwerp, Belgium between June 2017 and February 2020 were included in this study. Patients who did not return for a visit after October 30, 2019 and who were not transferred out were considered as having discontinued PrEP care. A total of 143/1073 patients were considered as having discontinued PrEP care. Patients who discontinued PrEP care were more likely to be younger than those who remained in care (35 vs. 38 years old, p < 0.01). The most common reasons for discontinuation were having stopped using PrEP (62/101, 61.4%) and "COVID-19" (n = 35, 34.7%). The most common reasons for stopping PrEP use was a decreased sexual activity due to coronavirus disease 2019 (COVID-19; 21/62, 33.9%) or not COVID-19 related (10/62, 16.1%), a monogamous relationship (20/62, 32.3%) and consistent condom use (7/62, 11.3%). Among respondents who reported about current HIV risk the majority reported being at low risk either by still taking PrEP (32/91, 35.2%), consistently using condoms, or limiting number of sex acts or partners (58/91, 52.7%). No HIV seroconversion was reported.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: HIV Infections / Pre-Exposure Prophylaxis / COVID-19 Type of study: Observational study / Prognostic study / Randomized controlled trials Limits: Adult / Humans / Male Country/Region as subject: Europa Language: English Journal: AIDS Patient Care STDS Journal subject: Sexually Transmitted Diseases / SINDROME DA IMUNODEFICIENCIA ADQUIRIDA (AIDS) Year: 2022 Document Type: Article Affiliation country: Apc.2021.0197

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: HIV Infections / Pre-Exposure Prophylaxis / COVID-19 Type of study: Observational study / Prognostic study / Randomized controlled trials Limits: Adult / Humans / Male Country/Region as subject: Europa Language: English Journal: AIDS Patient Care STDS Journal subject: Sexually Transmitted Diseases / SINDROME DA IMUNODEFICIENCIA ADQUIRIDA (AIDS) Year: 2022 Document Type: Article Affiliation country: Apc.2021.0197